+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group



Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group



Stroke 23(2 Suppl.): I29-I32



Antiphospholipid antibodies are a marker for an increased risk of thrombosis, including stroke and transient ischemic attacks. Prior studies suggest that patients with these antibodies and thrombosis may be at increased risk for recurrent thrombotic events. We prospectively evaluated 75 patients with antiphospholipid antibodies and cerebral or ocular ischemia for recurrence of thrombosis. Twenty-six patients (35%) experienced a recurrent stroke or transient ischemic attack, with a mean time to recurrence of 1.18 years. Hypertension significantly increased the risk of a recurrent transient ischemic attack. Patients with coronary artery disease were three times as likely as those without to have a recurrent stroke or transient ischemic attack. There was a trend for treatment with a combination of aspirin and dipyridamole to reduce the risk of recurrent thrombotic events after adjusting for sex and ethnicity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041278848

Download citation: RISBibTeXText

PMID: 1561671


Related references

Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 23(2 SUPPL 1): I29-I32, 1992

Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group. Stroke 21(9): 1268-1273, 1990

Recurrent thromboembolic and stroke risk in patients with neurological events and antiphospholipid antibodies. Annals of Neurology 28(2): 226, 1990

Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS). Neurology 48(1): 91-94, 1997

Antiphospholipid antibodies and recurrent thrombo-occlusive events The Antiphospholipid Antibodies and Stroke Study. Neurology 58(7 Suppl. 3): A257-A258, April 9, 2002

Prospective longitudinal study of antiphospholipid antibodies in patients with primary antiphospholipid antibody syndrome-correlation with thromboembolic events, treatment and outcome. Arthritis & Rheumatism 36(9 SUPPL ): S243, 1993

Clinical, radiological, and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group (APASS). Stroke 24(12 Suppl.): I120-I123, 1993

Factors associated with recurrent cerebral and ocular ischemia in patients with antiphospholipid antibodies aplab. Neurology 40(4 SUPPL 1): 353, 1990

Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Neurology 43(10): 2069-2073, 1993

Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clinical Reviews in Allergy and Immunology 43(3): 265-274, 2013

Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease. Mayo Clinic Proceedings 78(3): 294-298, 2003

Focal cerebral ischemia and antiphospholipid antibodies: A case for cardiac embolism. Acta Neurologica Scandinavica 90(6): 417-423, 1994

Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event. Clinical Rheumatology 2018, 2018

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstetrics & Gynecology. 89(4): 549-555, 1997

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 66(4): 540-546, 1996